Basic information Safety Related Supplier

ChemicalBook Product Catalog Echinomycin

1/1

Echinomycin NEW

$ 427.00 /1mg

Min. Order
Purity95.00%
Cas No512-64-1
Supply Ability10g
Update time2025-08-30

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP6Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Echinomycin
CAS No	512-64-1
EC-No
Min. Order
Purity	95.00%
Supply Ability	10g
Release date	2025/08/30

Product Introduction

Bioactivity

Name	Echinomycin
Description	Echinomycin (Quinomycin A) is an antitumor antibiotic secondary metabolite isolated from Streptomyces, a quinoxaline antibiotic, a DNA doubly intercalating peptide, and inhibits hypoxia-inducible factor-1 (HIF-1) DNA binding activity. Echinomycin has potential anticancer activity and can be used to study triple-negative breast cancer.
In vitro	Electrophoretic mobility shift assay experiments showed that Echinomycin inhibited binding of HIF-1α and HIF-1β proteins to a HRE sequence but not binding of the corresponding proteins to activator protein-1 (AP-1) or nuclear factor-κB (NF-κB) consensus sequences. Echinomycin very potently inhibited hypoxic induction of luciferase expression in U251-HRE in a dose-dependent fashion with an EC50 of ∼1.2 nmol/L. [1] Echinomycin abrogated the CSCs with an IC50 of 29.4 pM. Echinomycin selectively induces apoptosis of CSCs. The cultured lymphoma cells were treated with 20 pM echinomycin or vehicle in medium for 16 hr. [2]
In vivo	Cultured lymphoma cells were injected i.p. into immune-competent B10.BR mice or BALB Rag2−/−/c mice. Fourteen days later, 10 μg/Kg/injection of echinomycin was injected at a 2-day interval for a total of five times. The untreated mice survived only 6–10 weeks, while all treated mice lived until euthanasia at 134 or 252 days after tumor-cell injection, with no sign of tumor development upon necropsy. [2]
Storage	store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : 2 mg/mL (1.82 mM), Sonication is recommended.
Keywords	NSC13502 \| NSC 13502 \| Echinomycin \| antibiotic
Inhibitors Related	Neomycin sulfate \| Ampicillin sodium \| Doxycycline (hyclate) \| Cefaclor monohydrate \| Kanamycin sulfate \| Rifaximin \| Sulfamethoxazole sodium \| Metronidazole \| Doxycycline \| Penicillin G sodium salt \| EDTA copper(II) disodium salt \| Sulfachloropyridazine

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book